Related references
Note: Only part of the references are listed.Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
Ryan C. Anderson et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen
Yasir A. W. Skeiky et al.
VACCINE (2010)
Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers
Jaap T. van Dissel et al.
VACCINE (2010)
The candidate tuberculosis vaccine Mtb72F/AS02A Tolerability and immunogenicity in humans
Kenneth Von Eschen et al.
HUMAN VACCINES (2009)
Vaccine Potentials of an Intrinsically Unstructured Fragment Derived from the Blood Stage-Associated Plasmodium falciparum Protein PFF0165c
S. Olugbile et al.
INFECTION AND IMMUNITY (2009)
Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis
Carine Rouanet et al.
MICROBES AND INFECTION (2009)
Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
Zhou Xing et al.
PLOS ONE (2009)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Mark E. Polhemus et al.
PLOS ONE (2009)
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys
Steven G. Reed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
Ivan D. Velez et al.
VACCINE (2009)
Optimized subunit vaccine protects against experimental leishmaniasis
Sylvie Bertholet et al.
VACCINE (2009)
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
Susan L. Baldwin et al.
VACCINE (2009)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Identification of Human T Cell Antigens for the Development of Vaccines against Mycobacterium tuberculosis
Sylvie Bertholet et al.
JOURNAL OF IMMUNOLOGY (2008)
Synergistic effect of bacillus Calmette Guerin and a tuberculosis subunit vaccine in cationic liposomes: Increased immunogenicity and protection
Jes Dietrich et al.
JOURNAL OF IMMUNOLOGY (2007)
The success and failure of BCG - implications for a novel tuberculosis vaccine
P Andersen et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: Efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy
J Dietrich et al.
JOURNAL OF IMMUNOLOGY (2005)
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M-tuberculosis-infected guinea pigs
L Brandt et al.
INFECTION AND IMMUNITY (2004)
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
NP Goonetilleke et al.
JOURNAL OF IMMUNOLOGY (2003)
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
AW Olsen et al.
INFECTION AND IMMUNITY (2001)
Share Paper
